Trademark Overview
On Wednesday, September 11, 2024, a trademark application was filed for DYNAMICURE with the United States Patent and Trademark Office. The USPTO has given the DYNAMICURE trademark a serial number of 98745375. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, September 11, 2024. This trademark is owned by DynamiCure Biotechnology, LLC. The DYNAMICURE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
pharmaceutical preparations and substances for the treatment of autoimmune diseases and disorders, autoimmune deficiency; pharmaceutical preparation and substances for the treatment of genetic disorders; pharmaceutical preparations and substances for the treatment of metabolic diseases; pharmaceutical preparations and substances for the treatment of neurodegenerative diseases; pharmaceutical preparations and substances for the treatment of kidney diseases; diagnostic biomarker reagents for medical purposes; protein arrays for medical diagnosis purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations for medical purposes for detecting the presence of tumors, genetic disorder and autoimmune disorders and conditions; All of the foregoing excluding treatments and diagnostics for neuromuscular disorders and orphan diseases
Research and development services in the field of biologics, namely, antibodies and peptides for the field of autoimmune diseases, autoimmune disorders, metabolic diseases, neurodegenerative diseases, and kidney diseases; research and development in the pharmaceutical and biotechnology fields for the treatment of autoimmune diseases, autoimmune disorders, metabolic diseases, neurodegenerative diseases, and kidney diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials in the field of autoimmune diseases, autoimmune disorders, metabolic diseases, neurodegenerative diseases, and kidney diseases; consulting services in the fields of biotechnology, pharmaceutical research and development, and pharmacogenetics in the field of autoimmune diseases, autoimmune disorders, metabolic diseases, neurodegenerative diseases, and kidney diseases; conducting research for others in the field of biotechnology, pharmaceutical research and develop...
